NO20090812L - Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser - Google Patents
Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelserInfo
- Publication number
- NO20090812L NO20090812L NO20090812A NO20090812A NO20090812L NO 20090812 L NO20090812 L NO 20090812L NO 20090812 A NO20090812 A NO 20090812A NO 20090812 A NO20090812 A NO 20090812A NO 20090812 L NO20090812 L NO 20090812L
- Authority
- NO
- Norway
- Prior art keywords
- neurodegenerative
- cognitive
- treatment
- disorders
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Foreliggende oppfinnelse vedrører en familie av fenyl-prenyl-eter-derivater med formel (I), og deres anvendelse i behandlingen av kognitive, neurodegenerative eller neurone sykdommer eller lidelser, slik som Alzheimers sykdom eller Parkinsons Sykdom. Foreliggende oppfinnelse vedrører også farmasøytiske sammensetninger som omfatter det samme. Videre er foreliggende oppfinnelse rettet mot anvendelsen av forbindelsene i fremstillingen av et medikament for behandlingen og/eller forebyggingen av en kognitiv, neurodegenerativ eller neuron sykdom eller lidelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06380222A EP1886990A1 (en) | 2006-08-01 | 2006-08-01 | Phenyl-prenyl-ether derivatives for the treatment of cognitive neurodegenerative or neuronal diseases or disorders |
PCT/EP2007/057973 WO2008015241A1 (en) | 2006-08-01 | 2007-08-01 | Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090812L true NO20090812L (no) | 2009-02-20 |
Family
ID=37636079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090812A NO20090812L (no) | 2006-08-01 | 2009-02-20 | Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100267827A1 (no) |
EP (2) | EP1886990A1 (no) |
JP (1) | JP2009545566A (no) |
KR (1) | KR20090037955A (no) |
CN (1) | CN101516823A (no) |
AU (1) | AU2007280400A1 (no) |
BR (1) | BRPI0714580A2 (no) |
CA (1) | CA2658552A1 (no) |
IL (1) | IL196617A0 (no) |
MA (1) | MA30662B1 (no) |
MX (1) | MX2009001172A (no) |
NO (1) | NO20090812L (no) |
NZ (1) | NZ575191A (no) |
RU (1) | RU2009107132A (no) |
WO (1) | WO2008015241A1 (no) |
ZA (1) | ZA200900738B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5526018B2 (ja) * | 2007-03-21 | 2014-06-18 | エミスフェアー・テクノロジーズ・インク | アリルオキシおよびアルキルオキシ安息香酸送達薬剤 |
KR20110116018A (ko) | 2008-12-24 | 2011-10-24 | 에코바이오틱스 리미티드 | 운향 종들의 식물 추출물 및 이의 용도 |
DE102011085998A1 (de) | 2011-11-09 | 2013-05-16 | Henkel Ag & Co. Kgaa | Geschirrspülmittel enthaltend Emulgatoren |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH568708A5 (no) * | 1969-04-30 | 1975-11-14 | Hoffmann La Roche | |
NZ254881A (en) * | 1992-07-28 | 1996-09-25 | Rhone Poulenc Rorer Ltd | Diether, dithioether or diether thioether derivatives of 1,2-dihydroxybenzenes substituted in position-4 by an (hetero)aryl-containing group; |
JP3065506B2 (ja) * | 1995-04-03 | 2000-07-17 | 株式会社資生堂 | ピラゾリジン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤 |
JP4113602B2 (ja) * | 1997-04-04 | 2008-07-09 | 株式会社資生堂 | ピロリジン誘導体及び抗潰瘍剤、抗菌剤 |
JP3933244B2 (ja) * | 1997-04-04 | 2007-06-20 | 株式会社資生堂 | アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤 |
US7132568B2 (en) * | 2002-06-17 | 2006-11-07 | Sunesis Pharmaceuticals, Inc. | Aspartyl protease inhibitors |
JP2006523196A (ja) * | 2003-03-11 | 2006-10-12 | ニューロサーチ、アクティーゼルスカブ | 新規kcnqチャネルを調節する化合物及びその医薬用途 |
-
2006
- 2006-08-01 EP EP06380222A patent/EP1886990A1/en not_active Ceased
-
2007
- 2007-08-01 AU AU2007280400A patent/AU2007280400A1/en not_active Abandoned
- 2007-08-01 CN CNA200780034371XA patent/CN101516823A/zh active Pending
- 2007-08-01 RU RU2009107132/04A patent/RU2009107132A/ru not_active Application Discontinuation
- 2007-08-01 MX MX2009001172A patent/MX2009001172A/es not_active Application Discontinuation
- 2007-08-01 EP EP07802460A patent/EP2051958A1/en not_active Withdrawn
- 2007-08-01 US US12/375,607 patent/US20100267827A1/en not_active Abandoned
- 2007-08-01 ZA ZA200900738A patent/ZA200900738B/xx unknown
- 2007-08-01 JP JP2009522277A patent/JP2009545566A/ja not_active Withdrawn
- 2007-08-01 CA CA002658552A patent/CA2658552A1/en not_active Abandoned
- 2007-08-01 NZ NZ575191A patent/NZ575191A/en not_active IP Right Cessation
- 2007-08-01 WO PCT/EP2007/057973 patent/WO2008015241A1/en active Application Filing
- 2007-08-01 BR BRPI0714580-2A patent/BRPI0714580A2/pt not_active IP Right Cessation
- 2007-08-01 KR KR1020097003702A patent/KR20090037955A/ko not_active Application Discontinuation
-
2009
- 2009-01-20 IL IL196617A patent/IL196617A0/en not_active IP Right Cessation
- 2009-02-20 NO NO20090812A patent/NO20090812L/no not_active Application Discontinuation
- 2009-02-26 MA MA31662A patent/MA30662B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20100267827A1 (en) | 2010-10-21 |
BRPI0714580A2 (pt) | 2013-05-14 |
EP2051958A1 (en) | 2009-04-29 |
ZA200900738B (en) | 2010-05-26 |
KR20090037955A (ko) | 2009-04-16 |
NZ575191A (en) | 2011-04-29 |
JP2009545566A (ja) | 2009-12-24 |
MA30662B1 (fr) | 2009-08-03 |
CN101516823A (zh) | 2009-08-26 |
RU2009107132A (ru) | 2010-09-10 |
EP1886990A1 (en) | 2008-02-13 |
WO2008015241A1 (en) | 2008-02-07 |
MX2009001172A (es) | 2009-02-12 |
AU2007280400A1 (en) | 2008-02-07 |
IL196617A0 (en) | 2009-11-18 |
CA2658552A1 (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0315158A (pt) | Compostos de pirazol para o tratamento de distúrbios neurodegenarativos | |
WO2008002621A3 (en) | Benzyl-substituted quinolone m1 receptor positive allosteric modulators | |
NO20090321L (no) | Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte | |
NO20064726L (no) | Imidazolforbindelser for behandling av neurodegenerative forstyrrelser | |
TN2013000285A1 (en) | Novel heterocyclic derivatives and their use in the treatment of neurological disorders | |
EA200901373A1 (ru) | Аминогетероциклические соединения | |
MX2011007774A (es) | Derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
EA201170705A1 (ru) | Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1 | |
MX2009004908A (es) | Compuestos quimicos. | |
TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
NO20090166L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
NO20065717L (no) | Substituerte N-arylbenzamider og beslektede forbindelser for behandling av amyloidsykdommer og synukleinopatier. | |
MX2010003269A (es) | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. | |
NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
NO20090814L (no) | N-fenyl-prenylamin derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser | |
BR0315462A (pt) | Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação | |
MX2010002765A (es) | Derivado de 6-pirimidinil-pirimid-4-ona. | |
ATE552257T1 (de) | Positive allosterische chinolizidinon-m1- rezeptormodulatoren | |
MX2009007889A (es) | Derivados de 3-cinnolincarboxamida y su uso para el tratamiento del cancer. | |
WO2007017146A3 (en) | Use of collismycin and derivatives thereof as oxidative stress inhibitors | |
MX2009013482A (es) | Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas. | |
ATE371724T1 (de) | Behandlung neurodegenerativer krankheiten | |
NO20090812L (no) | Fenyl-prenyl-eter derivater for behandling av kognitive, neurodegenerative eller neurone sykdommer eller lidelser | |
WO2005097114A3 (en) | Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |